Totus Medicines Overview
- Year Founded
-
2019
- Status
-
Private
- Employees
-
36
- Latest Deal Type
-
Series B
- Latest Deal Amount
-
$66M
- Investors
-
6
Totus Medicines General Information
Description
Developer of chemical biology technologies designed to create therapeutics for untreatable diseases. The company's technology uses the power of covalent bonding and a proprietary technology platform for high-throughput drug discovery, enabling pharmaceutical developers to convert genetic discoveries into real drugs to treat cancer, Alzheimer's, infectious diseases and even aging.
Contact Information
Website
www.totusmedicines.comCorporate Office
- 1480 64th Street
- Emeryville, CA 94608
- United States
Corporate Office
- 1480 64th Street
- Emeryville, CA 94608
- United States
Totus Medicines Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Early Stage VC (Series B) | 15-Dec-2023 | $66M | Completed | Pre-Clinical Trials | ||
| 3. Early Stage VC (Series A2) | 09-Dec-2021 | Completed | Pre-Clinical Trials | |||
| 2. Seed Round | 01-Jan-2020 | $1000K | $1000K | Completed | Startup | |
| 1. Accelerator/Incubator | Completed | Startup |
Totus Medicines Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A-2 | ||||||||
| Series A-1 |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Totus Medicines Comparisons
Industry
Financing
Details
Totus Medicines Competitors (9)
One of Totus Medicines’s 9 competitors is GlycosBio, a Venture Capital-Backed company based in Houston, TX.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| GlycosBio | Venture Capital-Backed | Houston, TX | ||||
| Larimar Therapeutics | Formerly VC-backed | Bala Cynwyd, PA | ||||
| Psygen | Venture Capital-Backed | Calgary, Canada | ||||
| Conagen | Corporate Backed or Acquired | Bedford, MA | ||||
| Definium Therapeutics | Formerly VC-backed | New York, NY |
Totus Medicines Patents
Totus Medicines Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4784138-A1 | Pharmaceutical compositions and methods of use thereof | Pending | 27-Sep-2023 | ||
| WO-2025072796-A1 | Pharmaceutical compositions and methods of use thereof | Inactive | 27-Sep-2023 | ||
| WO-2024220380-A2 | Pi3k assays and probe compounds therein | Inactive | 16-Apr-2023 | ||
| WO-2024220380-A3 | Pi3k assays and probe compounds therein | Inactive | 16-Apr-2023 | ||
| EP-4604963-A2 | Covalent inhibitors of wild-type and mutant pi3k and method of uses thereof | Pending | 18-Oct-2022 | A61K31/5377 |
Totus Medicines Signals
Totus Medicines Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Camford Capital | Venture Capital | Minority | ||
| DCVC Bio | Venture Capital | Minority | ||
| DHVC | Venture Capital | Minority | ||
| Northpond Ventures | Venture Capital | Minority | ||
| Social Impact Capital | Venture Capital | Minority |
Totus Medicines FAQs
-
When was Totus Medicines founded?
Totus Medicines was founded in 2019.
-
Where is Totus Medicines headquartered?
Totus Medicines is headquartered in Emeryville, CA.
-
What is the size of Totus Medicines?
Totus Medicines has 36 total employees.
-
What industry is Totus Medicines in?
Totus Medicines’s primary industry is Drug Discovery.
-
Is Totus Medicines a private or public company?
Totus Medicines is a Private company.
-
What is the current valuation of Totus Medicines?
The current valuation of Totus Medicines is .
-
What is Totus Medicines’s current revenue?
The current revenue for Totus Medicines is .
-
How much funding has Totus Medicines raised over time?
Totus Medicines has raised $107M.
-
Who are Totus Medicines’s investors?
Camford Capital, DCVC Bio, DHVC, Northpond Ventures, and Social Impact Capital are 5 of 6 investors who have invested in Totus Medicines.
-
Who are Totus Medicines’s competitors?
GlycosBio, Larimar Therapeutics, Psygen, Conagen, and Definium Therapeutics are some of the 9 competitors of Totus Medicines.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process